After the creation phase involving an investment of above USD 5 billion with 10 patents and new products lined up for the launch, DiaSys India recently unveiled its new facility DiaSys India New House in Mahape, Navi Mumbai – 20 km away from Mumbai city. With 30,000 sq. ft. area fully equipped with the most modern technologies for R&D and production, DiaSys India secures its long term presence and contribution to healthcare and quality diagnostics in India.

DiaSys excels in the field of research, manufacturing, and marketing of superior- quality diagnostic products to laboratories, hospitals, and physicians in more than 100 countries.

Dr Guenther Gorkha and Dr Manfred Probst founded this company 26 years ago in a little village near Frankfurt, in Germany. Since its inception in 1991, DiaSys was the first company to introduce liquid stable biochemistry reagents for determination of enzymes and substrates with dedicated calibrators and controls. This novelty combined with a focus on quality was a breakthrough in the industry.

The entire IVD industry then followed the trend set by DiaSys into the market of fluid stable reagents. The reagents of DiaSys stand unique in their composition and also in their wide measuring range securing a better diagnostics evaluation and, therefore, improved patient care.

DiaSys' motto Choosing Quality assures its customers of the best quality products and services, taking camaraderie between DiaSys and its channel partners to the highest level. The focus has always been on quality and innovation and this has only improved with time. DiaSys firmly believes that an early and accurate diagnosis improves therapy and makes it more efficient, while reducing the costs of therapy.

Over a period of time, DiaSys has expanded itself throughout the globe with a series of daughter companies in Brazil, France, Japan, USA, China, and Indonesia, bringing its reagents and its own range of biochemistry instruments.

In September 2014, DiaSys Diagnostics acquired the diagnostic arm of Piramal Healthcare to officially launch DiaSys India. Since then, a lot of business development, R&D, and marketing has shaped the growth of DiaSys in a short time frame.

DiaSys India has developed a clear vision:

  • To be a respectable member of the DiaSys family with the same quality standards and requirements
  • To be a preferred partner to the testing sites all over India
  • To become an innovative point-of-care testing specialist, building a pillar to the worldwide DiaSys Strategy, and therefore exporting internationally out of DiaSys India

Over the past two and a half years, under the leadership of Bertrand de Castelnau, CEO of DiaSys Diagnostic India Pvt. Ltd., DiaSys boasts more than 150 employees in India, sustaining like a big family through all the thick and thin and the bumpy road in initial few months.

Keeping its aggressive expansion plans and vision in mind, DiaSys India is glad to shift its facilities to spacious state-of-the-art premises to Navi Mumbai which is an upcoming hub for newly incorporated companies mainly related to healthcare, IT, and many other start-ups that have established their base there.

DiaSys has set the benchmark toward trustworthy diagnostic indication – for reliable assistance to the doctor as well as for the benefit of the well-treated patient. DiaSys aims at contributing with a high- quality standard to the improvement of healthcare in India with Developed in India and Made in India products.


A New Cancer Treatment

10 Unbelievable Innovation in Medicine

 

Digital version